A non -hormonal male contraceptive results during the clinical test phase and can be on sale as of 2028 as explained by the method responsible for the method last week. The so -called man will be an alternative to vasectomy.
According to the biotechnology company, Treatment showed security and activity even after two years of application. Recently, the two volunteers who first reached Azoospermia, which was the lack of sperm in the ejaculated semen.
In addition, there are other participants who have continuous activity recorded in 12, 15, 18 and 21 months through semen analysis in laboratory and household tests. From these results, the manufacturer decided to advance the experiments for the next stage, which has already received the regulatory approval.
“No other method can provide permanent (two years), non -hormonal and temporary birth control.” Businesscience. He also commented on this Volunteers who tested the man contraceptive had no serious negative effects.
How does man work male contraceptives?
Developed new male contraceptive method acts as a injected hydrogel and a kind of obstacle. It allows you to temporarily block sperm passage from the defensive channel, a channel that connects the urethra and testicles.
In order to achieve this, the gel must be applied in the office with a maximum period of 30 minutes. The man has a long -term effect on preventing sperm movement without affecting ejaculation and dispersing continuous applications.

According to controline, treatment has no negative effect on the libido, which normally makes it possible to follow sexual intercourse. And at the end of its event, The gel is dissolved to the body without causing any damage and the normal sperm flow is restored..
Therefore, the user does not have to have surgery as in vasectomy. Another advantage is the possibility of recovery of reproductive capacity, which is considered to be an option for permanent birth control, which is not a guarantee in the traditional technique.
When do the next tests start?
With promising results in the tests of the contraceptive of new men, the manufacturer is now going to the next stage of clinical research, It will be held in Australia from the third quarter of this year. At this stage, the Contaline expects to buy at least 30 people.
According to Eisenfrats, it will not be a problem to find stakeholders because the company is a waiting list of 15,000 names. “I believe that men are more open to new male contraceptives 20, 30, 40 years ago. There is no doubt that there is a demand from consumers.” He said.
He also said that the next step was expected with high expectation because similar research did not show security, effectiveness and reversibility after the second stage. If everything goes well, the manager believes that man will be available at some point in 2028.
Do you like the content? Continue to update about technology and science at Tecmundo and make sure you share the news on social networks.
Source: Tec Mundo

I’m Blaine Morgan, an experienced journalist and writer with over 8 years of experience in the tech industry. My expertise lies in writing about technology news and trends, covering everything from cutting-edge gadgets to emerging software developments. I’ve written for several leading publications including Gadget Onus where I am an author.